REFRAMING WOMEN’S HEALTH AS A SYSTEM-WIDE AGENDA ACROSS INNOVATION, REGULATION, WORKFORCE AND POLICY
With
Professor Robyn Norton AO
Founding Director, The George Institute for Global Health &
Professor of Public Health,
Faculty of Medicine, UNSW Sydney &
Emeritus Professor, Imperial College London
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | July 2026
In May 2026, Professor Robyn Norton AO, played a prominent role at the inaugural Medical Technology Association of Australia (MTAA) Women’s Health MedTech Summit, Breaking the Silos, held in Sydney.
Professor Robyn Norton AO FAHMS is one of the two Founding Directors of The George Institute for Global Health, Professor of Public Health at UNSW Sydney and Emeritus Professor of Global Health at Imperial College London. Robyn co-established The George Institute’s Global Women’s Health Program and more recently the Centre for Sex and Gender Equity in Health and Medicine, where she co-leads the Business Translation Working Group. Robyn is a director on the board of the Black Dog Institute, a member of the Women in MedTech Committee of the MTAA and a member of Chief Executive Women. She also chairs the NHMRC’s Gender Guidelines Development Committee and the Advisory Board of the Network of Excellence in Women’s Health at Imperial College London.
Suiting her significant contribution to global health research, her involvement extended beyond being a keynote speaker—she helped frame the strategic direction of the summit and the broader conversation around women’s health innovation in Australia.
The summit itself was designed to address longstanding gaps in women’s health research, medical technology, clinical trials and policy by bringing together clinicians, researchers, industry, investors, government and consumer advocates. Following the event, MTAA reported that almost 200 participants attended and used the discussions to inform a Women’s Health Action Plan aimed at driving future MedTech policy and innovation.
Australian Health Journal spoke with Professor Norton on her research journey, the early stages of the George Institute for Global Health and the priorities for advancing women’s health.
Source: Adapted from MTAA Women’s Health MedTech Summit speaker profile and agenda
Media access credit: Medical Technology Association of Australia (MTAA)
-
New Generative AI and machine learning frontier on unused patient care data
Drawing from GE’s 125-year legacy in healthcare, Amit Yadav, CEO GE HealthCare ANZ is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
-
SAHMRI Celebrates 10 Years of Research
SAHMRI represents an exciting and unique statewide concept, bringing together basic and translational research, South Australia’s three universities and the health system. SAHMRI works in collaboration with its partners to provide a clear focal point for health and medical research, including paving the way for new partnerships, innovative research projects and improved health outcomes.
Executive Director, Professor Maria Makrides spoke to Australian Health Journal about 3 achievements in the past 10 years that have had significant impact
International leadership breakthroughs in leukaemia research
Culturally appropriate Indigenous health research and clinical care
Omega 3 fatty acids as a preterm birth prevention -
Significant funding announced for NSW biomedical researchers
The Snow Medical Research Foundation (Snow Medical) has announced a new $24 million investment in three outstanding Australian biomedical researchers through its prestigious Snow Fellowships.
These Fellows will tackle major global health challenges spanning autoimmune disease, neurological disorders, and genetic disease. Their work addresses conditions that disproportionately affect vulnerable and underserved populations, including First Nations communities, while advancing precision medicine and translational care. Collectively, their research aims to deliver safer vaccines, better diagnostics, and more equitable genomic and neurological healthcare.
